ArticleJMA journal2025

Improvement of Quality of Life by Switching from Oral Semaglutide to Tirzepatide in Patients with Type 2 Diabetes.

Takahiro Fukaishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.